 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Cystospaz.
No reviews have yet been submitted. Be the first to review this drug.
Pregnancy Category Risk cannot be ruled out
Feb 8, 2012 - Ironwood Pharmaceuticals, Inc. announced that it was informed this evening that the U.S. Food and Drug Administration (FDA) will not schedule...
Inflammatory bowel disease (IBD) is becoming more common around the world, according to a new study. Researchers who analyzed data from all population-based...
Some patients with inflammatory bowel disease may be at increased risk for skin cancer due to their use of immunosuppressant drugs to treat the intestinal...
Guide to Cimzia® (certolizumab pegol) data for science writers attending American College of Gastroenterology 2011 Annual Scientific Meeting ATLANTA--Oct....
Oct. 31, 2011--(BUSINESS WIRE)--Furiex Pharmaceuticals, Inc. (Nasdaq: FURX), a drug development collaboration company, announced its late-breaking...
Looking for answers? Ask a question or go join the Cystospaz support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
